|
Real-time Estimate
Cboe BZX
16:54:42 08/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 20.02 USD | -1.11% |
|
-1.80% | -13.67% |
| 09-21 | Damora Therapeutics, Inc.(NasdaqCM:DMRA) added to S&P Global BMI Index | CI |
| 08-10 | Damora Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.11% | -1.80% | -31.90% | -27.84% | -13.67% | +86.53% | +25.13% | -76.49% | - | 1.25B | |
| +4.16% | +4.16% | +8.78% | +36.08% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.68B | |
| -12.93% | -13.24% | -15.66% | -8.70% | +1.87% | +6.26% | +56.36% | +186.02% | +4,867.35% | 58.7B | |
| -1.56% | +1.14% | +1.98% | -1.05% | +5.43% | +4.07% | +32.17% | -18.02% | +204.02% | 48.36B | |
| -5.04% | -5.29% | -5.94% | +2.76% | +144.82% | +307.78% | +665.61% | +601.94% | - | 43.05B | |
| -0.55% | -2.58% | -2.02% | +24.63% | +12.68% | +26.61% | +27.29% | +4.85% | +218.24% | 42.48B | |
| -4.22% | -2.15% | -0.12% | +16.29% | +15.55% | -0.01% | +103.17% | -3.36% | +993.27% | 41.39B | |
| -0.11% | +1.96% | -3.03% | +3.70% | +5.81% | +9.19% | +52.66% | +4.65% | +144.87% | 31.29B | |
| -1.26% | -4.06% | -5.82% | -0.65% | -2.39% | -12.57% | -14.99% | -62.22% | - | 23.93B | |
| -2.59% | -9.28% | -21.12% | -15.47% | -43.40% | -39.12% | +301.91% | +246.13% | +555.41% | 22.22B | |
| -4.26% | +1.58% | +11.16% | +25.49% | +17.41% | +13.71% | -2.34% | -15.18% | +109.51% | 22.24B | |
| -0.62% | -0.30% | +0.92% | +12.09% | +6.17% | +12.30% | +140.49% | +215.84% | +1,871.24% | 16.87B | |
| -1.26% | -1.67% | -10.31% | -9.80% | +177.32% | +133.17% | +348.50% | +1,873.29% | +667.33% | 15.67B | |
| -0.24% | +2.41% | +7.22% | +13.84% | +22.34% | +22.54% | +46.69% | -27.84% | +84.64% | 14.87B | |
| -0.74% | -0.19% | -16.00% | -18.15% | - | - | - | - | - | 15B | |
| -2.01% | +1.79% | +3.99% | +30.36% | +46.36% | +68.30% | +51.21% | -28.65% | +249.72% | 14.34B | |
| +0.11% | +0.39% | +0.86% | +3.66% | +32.71% | +50.53% | +170.66% | +169.03% | +361.26% | 14.48B | |
| -3.87% | +2.94% | -0.58% | +9.50% | -1.77% | -26.39% | +928.74% | +244.98% | +44.61% | 14.36B | |
| -2.01% | -12.29% | +4.36% | +17.16% | +13.62% | -35.02% | - | - | - | 12.69B | |
| -1.66% | -1.23% | +0.96% | -3.39% | -12.27% | -14.27% | -32.99% | -39.73% | +102.30% | 12.66B | |
| Average | -2.13% | -1.61% | -3.61% | +5.52% | +27.01% | +34.89% | +166.36% | +182.49% | +748.13% | 27.03B | |
| Weighted average by Cap. | -2.40% | -1.21% | -2.14% | +9.33% | +34.22% | +40.91% | +153.28% | +152.22% | +1,133.42% |
- Stock Market
- Stocks
- DMRA Stock
- Sector Damora Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
